Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Zijun Zhen, Jia Zhu, Juan Wang, Suying Lu, Feifei Sun, Junting Huang & Xiaofei Sun. (2020) Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R4. Pediatric Hematology and Oncology 37:6, pages 489-499.
Read now
Read now
Jorge J Castillo & Omar Nadeem. (2014) Improving the accuracy in prognosis for Burkitt lymphoma patients. Expert Review of Anticancer Therapy 14:2, pages 125-127.
Read now
Read now
Articles from other publishers (20)
Yan-Feng Xu, Guan-Yun Wang, Ming-Yu Zhang & Ji-Gang Yang. (2023) Hub genes and their key effects on prognosis of Burkitt lymphoma. World Journal of Clinical Oncology 14:10, pages 357-372.
Crossref
Crossref
Sugeeth MT, Geetha Narayanan, Anoop TM, Sreejith G Nair, Prakash NP, Jagathnath Krishna KM & Rekha A Nair. (2023) Treatment Outcome of Burkitt's Lymphoma in Adolescents and Adults: A Retrospective Study. Indian Journal of Medical and Paediatric Oncology.
Crossref
Crossref
Andrew M. Evens. (2021) Burkitt Lymphoma. Oncology Times 43:7, pages 1,10-11.
Crossref
Crossref
Adam J. Olszewski, Lasse H. Jakobsen, Graham P. Collins, Kate Cwynarski, Veronika Bachanova, Kristie A. Blum, Kirsten M. Boughan, Mark Bower, Alessia Dalla Pria, Alexey Danilov, Kevin A. David, Catherine Diefenbach, Fredrik Ellin, Narendranath Epperla, Umar Farooq, Tatyana A. Feldman, Alina S. Gerrie, Deepa Jagadeesh, Manali Kamdar, Reem Karmali, Shireen Kassam, Vaishalee P. Kenkre, Nadia Khan, Seo-Hyun Kim, Andreas K. Klein, Izidore S. Lossos, Matthew A. Lunning, Peter Martin, Nicolas Martinez-Calle, Silvia Montoto, Seema Naik, Neil Palmisiano, David Peace, Elizabeth H. Phillips, Tycel J. Phillips, Craig A. Portell, Nishitha Reddy, Anna Santarsieri, Maryam Sarraf Yazdy, Knut B. Smeland, Scott E. Smith, Stephen D. Smith, Suchitra Sundaram, Adam S. Zayac, Xiao-Yin Zhang, Catherine Zhu, Chan Y. Cheah, Tarec C. El-Galaly & Andrew M. Evens. (2021) Burkitt Lymphoma International Prognostic Index. Journal of Clinical Oncology 39:10, pages 1129-1138.
Crossref
Crossref
Hyung-Don Kim, Hyungwoo Cho, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Chan-Sik Park, Jooryung Huh, Jin Sook Ryu, Sang-Wook Lee, Dok-Hyun Yoon, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim & Cheolwon Suh. (2020) Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels. Cancer Research and Treatment.
Crossref
Crossref
Rami Alsharif & Kieron Dunleavy. (2019) Burkitt Lymphoma and Other High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 Rearrangements. Hematology/Oncology Clinics of North America 33:4, pages 587-596.
Crossref
Crossref
T. Wästerlid, M. Mohammadi, K. E. Smedby, I. Glimelius, M. Jerkeman, M. Bottai & S. Eloranta. (2018) Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B‐cell lymphoma: a Swedish lymphoma register study. Journal of Internal Medicine 285:4, pages 455-468.
Crossref
Crossref
Holger Dau, Philipp Kurz & Marc-Denis WeitzeKieron Dunleavy & Martine Chamuleau. 2019. Künstliche Photosynthese. Künstliche Photosynthese
167
175
.
Kieron Dunleavy. (2018) Approach to the Diagnosis and Treatment of Adult Burkitt's Lymphoma. Journal of Oncology Practice 14:11, pages 665-671.
Crossref
Crossref
Tadanobu Nagaya, Yuko Nakamura, Kazuhide Sato, Toshiko Harada, Peter L. Choyke & Hisataka Kobayashi. (2016) Near infrared photoimmunotherapy of B‐cell lymphoma. Molecular Oncology 10:9, pages 1404-1414.
Crossref
Crossref
Valentin Koechli, Bernd Klaeser, Yara Banz, Beatrice U. Mueller & Thomas Pabst. (2015) Consolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma. Leukemia Research 39:3, pages 307-310.
Crossref
Crossref
Tanya M. Wildes, Laura Farrington, Cecilia Yeung, Alexandra M. Harrington, Kelley V. Foyil, Jingxia Liu, Friederike Kreisel, Nancy L. Bartlett & Timothy S. Fenske. (2013) Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers. Therapeutic Advances in Hematology 5:1, pages 3-12.
Crossref
Crossref
A.S. Roug, P. Wendtland, K. Bendix & E. Kjeldsen. (2014) Supernumerary Isochromosome 1, idic(1)(p12), Leading to Tetrasomy 1q in Burkitt Lymphoma. Cytogenetic and Genome Research 142:1, pages 7-13.
Crossref
Crossref
Nicola Gökbuget, Paul Barr, Jonathan W. Friedberg, Eric D. Hsi & German Ott. 2014. Rare Lymphomas. Rare Lymphomas
171
194
.
Jorge J. Castillo, Eric S. Winer & Adam J. Olszewski. (2013) Population-based prognostic factors for survival in patients with Burkitt lymphoma: An analysis from the Surveillance, Epidemiology, and End Results database. Cancer 119:20, pages 3672-3679.
Crossref
Crossref
T. Wästerlid, P.N. Brown, O. Hagberg, H. Hagberg, L.M. Pedersen, F. D'Amore & M. Jerkeman. (2013) Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Annals of Oncology 24:7, pages 1879-1886.
Crossref
Crossref
S O Ahmed, A Sureda & M Aljurf. (2012) The role of hematopoietic SCT in adult Burkitt lymphoma. Bone Marrow Transplantation 48:5, pages 617-629.
Crossref
Crossref
Josep‐Maria Ribera, Olga García, Carlos Grande, Jordi Esteve, Albert Oriol, Juan Bergua, José González‐Campos, Ferran Vall‐llovera, Mar Tormo, Jesús‐Maria Hernández‐Rivas, Daniel García, Salut Brunet, Natalia Alonso, Pere Barba, Pilar Miralles, Andreu Llorente, Pau Montesinos, Maria‐José Moreno, Jose‐Ángel Hernández‐Rivas & Teresa Bernal. (2013) Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status. Cancer 119:9, pages 1660-1668.
Crossref
Crossref
Sun-Joo Jang, Dok Hyun Yoon, Shin Kim, Shinkyo Yoon, Dal Yong Kim, Chan-Sik Park, Jooryung Huh, Sang-Wook Lee, Dae Ho Lee, Jin-Sook Ryu & Cheolwon Suh. (2012) A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience. Annals of Hematology 91:12, pages 1917-1922.
Crossref
Crossref
Gaetano Corazzelli, Ferdinando Frigeri, Filippo Russo, Chiara Frairia, Manuela Arcamone, Gennaro Esposito, Annarosaria De Chiara, Emanuela Morelli, Gaetana Capobianco, Cristina Becchimanzi, Francesco Volzone, Mariangela Saggese, Giampaolo Marcacci, Rosaria De Filippi, Umberto Vitolo & Antonio Pinto. (2012) RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ?unclassifiable? highly aggressive B-cell lymphoma. British Journal of Haematology 156:2, pages 234-244.
Crossref
Crossref